CARL ZEISS MEDITEC’S NEAR-TERM OUTLOOK DIMS (SELL; 11% DOWNSIDE)
16/11/20 -"At the start of 2020, Carl Zeiss Meditec/CZM (Sell, Germany) was trading at its life-time high levels as the FY 18/19 (ending September 2019) sales growth and operating margin hit record highs – ..."
Pages
59
Language
English
Published on
16/11/20
You may also be interested by these reports :
10/02/26
Philips’ Q4 results exceeded expectations, with comparable sales growth driven by strong performance in Personal Health and healthy contributions ...
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...
06/02/26
Qiagen’s Q4 results surpassed both market expectations and management’s guidance, with most segments reporting gains. The 2026 guidance aligns with ...
05/02/26
GN’s Q4 results fell short of market expectations. While Hearing experienced healthy growth, this was overshadowed by weaknesses in Gaming and ...